Headband that uses sound waves could ease Kids' nasal congestion
NCT ID NCT06773013
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This completed trial tested a wearable headband called Sonu that uses sound waves to relieve moderate to severe nasal congestion in children aged 12 to 21. The device works by sending gentle vibrations through the skull to clear the nasal passages. Researchers measured safety and how well it reduced congestion symptoms in 31 participants.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Acoustic Resonance (Sound) Therapy via a wearable headband and smartphone app
- What this could lead to
- If it works, this could offer a drug-free way to relieve nasal congestion in children and teens.
- What could go wrong
- This is a small, early-stage trial with only 31 participants. The device may not work for everyone, and long-term effects are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
31 people
The number who actually took part.
- Started
-
Jan 2025
- Finished
-
Mar 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
12 to 21 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Pediatric subjects between the ages of 12 to 21 years * Present with symptoms of nasal congestion for 1 month or more prior to treatment * Have a 24 hour reflective nasal congestion subscore of the TNSS of 2 or more on a 0 to 3 scale at the time of screening Exclusion Criteria: * Head, nasal or sinus surgery within 3 months * Sinus infection diagnosed within the last month, or rhinitis medicamentosa * Documented history of nasal polyposis or mass * Pregnancy
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Nasal congestion and inflammations are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Crescendo MD
Portola Valley, California, 94028, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.